Abstract
Cardiovascular diseases are characterized by high rates of morbidity and mortality. Microbiota are closely associated with cardiovascular disease. There is much evidence that supports the aetiology of many cardiovascular diseases (CVD), and related risk states such as hypertension, atherosclerosis, coronary artery diseases, myocardial infarction, obesity or dyslipidaemia, heart failure, chronic kidney diseases, and diabetes mellitus may be influenced by gut microbial dysbiosis. In addition to dysbiosis, the metabolic potential of gut microbiota (producing bioactive metabolites) also has an effect on host physiology since it enters the systemic circulation and may amplify the inflammatory response. Moreover, it has been shown to be a risk factor for cardiovascular disorders. There are several mechanisms by which the microbiota communicates with the host, including the trimethylamine/trimethylamine N-oxide pathway, the short-chain fatty acid pathway, and the primary and secondary bile acid pathways. It has been hypothesized that these pathways may also play a role in the development of cardiovascular disease. This chapter is mostly about learning about the dynamic relationship between the gut microbiota and cardiovascular disease, with a focus on the pathogenic mechanisms and therapeutic implications of hypertension, atherosclerosis, coronary artery diseases, myocardial infarction, obesity or dyslipidaemia, heart failure, chronic kidney diseases, and diabetes mellitus.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akbar H, Foth C, Kahloon RA, Mountfort S (2020) Acute myocardial infarction ST elevation (STEMI). In: StatPearls. StatPearls Publishing LLC, Treasure Island
Al Khodor S, Reichert B, Shatat IF (2017) The microbiome and blood pressure: can microbes regulate our blood pressure? Front Pediatr 19(5):138. https://doi.org/10.3389/fped.2017.00138
Almeida A, Mitchell AL, Boland M, Forster SC, Gloor GB, Tarkowska A, Lawley TD, Finn RD (2019) A new genomic blueprint of the human gut microbiota. Nature 568(7753):499–504. https://doi.org/10.1038/s41586-019-0965-1
Armani RG, Ramezani A, Yasir A, Sharama S, Canziani ME, Raj DS (2017) Gut microbiome in chronic kidney disease. Curr Hypertens Rep 19(4):1–8
Atarashi K, Tanoue T, Shima T et al (2011) Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331:337–341
Atarashi K, Tanoue T, Ando M et al (2015) Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell 163:367–380
Avershina E, Lundgård K, Sekelja M, Dotterud C, Storrø O, Øien T, Johnsen R, Rudi K (2016) Transition from infant-to adult-like gut microbiota. Environ Microbiol 18(7):2226–2236
Boccella N, Paolillo R, Coretti L, D’Apice S, Lama A, Giugliano G, Schiattarella GG, Cuomo M, d’Aquino I, Cavaliere G, Paciello O (2021) Transverse aortic constriction induces gut barrier alterations, microbiota remodeling and systemic inflammation. Sci Rep 11(1):1
Brown JM, Hazen SL (2015) The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases. Annu Rev Med 66:343–359
Caesar R, Fak F, Backhed F (2010) Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism. J Intern Med 268(4):320–328
Caesar R, Tremaroli V, Kovatcheva-Datchary P, Cani PD, Bäckhed F (2015) Crosstalk between gut microbiota and dietary lipids aggravates WAT inflammation through TLR signaling. Cell Metab 22:658–668
Cantarel BL, Lombard V, Henrissat B (2012) Complex carbohydrate utilization by the healthy human microbiome. PLoS One 7:e28742
Chen X, Li HY, Hu XM, Zhang Y, Zhang SY (2019) Current understanding of gut microbiota alterations and related therapeutic intervention strategies in heart failure. Chin Med J 132(15):1843–1855
Chockalingam A (2007) Impact of world hypertension day. Can J Cardiol 23(7):517–519. https://doi.org/10.1016/s0828-282x(07)70795-x
Claesson MJ, Jeffery IB, Conde S et al (2012) Gut microbiota composition correlates with diet and health in the elderly. Nature 488:178–184
Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT (1987) Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28:1221–1227
De Filippo C, Cavalieri D, Di Paola M et al (2010) Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 107:14691–14696
De Santis S, Cavalcanti E, Mastronardi M, Jirillo E, Chieppa M (2015) Nutritional keys for intestinal barrier modulation. Front Immunol 6:612
Demetris AJ, Zerbe T, Banner B (1989) Morphology of solid organ allograft arteriopathy: identification of proliferating intimal cell populations. Transplant Proc 1:3667–3669
Den Besten G, Bleeker A, Gerding A, van Eunen K, Havinga R, van Dijk TH, Oosterveer MH, Jonker JW, Groen AK, Reijngoud DJ, Bakker BM (2015) Short-chain fatty acids protect against high-fat diet–induced obesity via a PPARγ-dependent switch from lipogenesis to fat oxidation. Diabetes 64(7):2398–2408
Diaz Heijtz R, Wang S, Anuar F, Qian Y, Bjorkholm B, Samuelsson A, Hibberd ML, Forssberg H, Pettersson S (2011) Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A 108:3047–3052
Ding Y et al (2012) Toll-like receptor 4 deficiency decreases atherosclerosis but does not protect against inflammation in obese low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 32(7):1596–1604
Donaldson GP, Lee SM, Mazmanian SK (2016) Gut biogeography of the bacterial microbiota. Nat Rev Microbiol 14:20–32
Duncan SH, Louis P, Thomson JM et al (2009) The role of pH in determining the species composition of the human colonic microbiota. Environ Microbiol 11:2112–2122
Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA (2005) Diversity of the human intestinal microbial flora. Science 308(5728):1635–1638
Evenepoel P, Bammens B, Verbeke K, Vanrenterghem Y (2006) Acarbose treatment lowers generation and serum concentrations of the protein-bound solute p-cresol: a pilot study. Kidney Int 70(1):192–198
Flint HJ, Scott KP, Louis P et al (2012) The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol 9:577–589
Freeland KR, Wolever TM (2010) Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-α. Br J Nutr 103(3):460–466
Fujimoto T, Imaeda H, Takahashi K et al (2013) Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn’s disease. J Gastroenterol Hepatol 28:613–619
Furusawa Y, Obata Y, Fukuda S et al (2013) Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504:446–450
Gan XT et al (2014) Probiotic administration attenuates myocardial hypertrophy and heart failure after myocardial infarction in the rat. Circ Heart Fail 7(3):491–499
Gao J, Yan KT, Wang JX, Dou J, Wang J, Ren M, Ma J, Zhang X, Liu Y (2020) Gut microbial taxa as potential predictive biomarkers for acute coronary syndrome and post-STEMI cardiovascular events. Sci Rep 10:2639. https://doi.org/10.1038/s41598-020-59235-5
Girard SA et al (2009) Lactobacillus helveticus and bifidobacterium longum taken in combination reduce the apoptosis propensity in the limbic system after myocardial infarction in a rat model. Br J Nutr 102(10):1420–1425
Grice EA, Segre JA (2011) E skin microbiome. Nat Rev Microbiol 9(4):244–253
Grillo A, Salvi L, Coruzzi P, Salvi P, Parati G (2019) Sodium intake and hypertension. Nutrients 11(9):1970. https://doi.org/10.3390/nu11091970
Guarner F (2005) The intestinal flora in inflammatory bowel disease: normal or abnormal? Curr Opin Gastroenterol 21:414–418
Guarner F, Malagelada JR (2003) Gut flora in health and disease. Lancet 361:512–519
Guo Z et al (2011) Influence of consumption of probiotics on the plasma lipid profile: a meta-analysis of randomised controlled trials. Nutr Metab Cardiovasc Dis 21(11):844–850
Gurung M, Li Z, You H, Rodrigues R, Jump DB, Morgun A, Shulzhenko N (2020) Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine 51:102590
Haghikia A, Li XS, Liman TG, Bledau N, Schmidt D, Zimmermann F et al (2018) Gut microbiota-dependent trimethylamine N-oxide predicts risk of cardiovascular events in patients with stroke and is related to proinflammatory monocytes. Arterioscler Thromb Vasc Biol 38:2225–2235
Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352(16):1685–1695
Hasan N, Yang H (2019) Factors affecting the composition of the gut microbiota, and its modulation. PeerJ 7:e7502
Henao-Mejia J et al (2012) Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482(7384):179–185
Hoeppli RE, Wu D, Cook L, Levings MK (2015) Environment of regulatory T cell biology: cytokines, metabolites, and the microbiome. Front Immunol 6:e1002808
Hollister EB, Gao C, Versalovic J (2014) Compositional and functional features of the gastrointestinal microbiome and their effects on human health. Gastroenterology 146:1449–1458
Holmes E, Loo R, Stamler J, Bictash M, Yap I, Chan Q et al (2008) Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 453(7193):396–400. https://doi.org/10.1038/nature06882
Hooper LV, Macpherson AJ (2010) Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol 10:159–169
Ikeda Y, Ishii S, Yazaki M, Fujita T, Iida Y, Kaida T, Nabeta T, Nakatani E, Maekawa E, Yanagisawa T, Koitabashi T (2018) Portal congestion and intestinal edema in hospitalized patients with heart failure. Heart Vessel 33(7):740–751
Ivanov II, FrutosRde L, Manel N et al (2008) Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4:337–349
Jie Z, Xia H, Zhong SL, Feng Q, Li S, Liang S, Zhong H, Liu Z, Gao Y, Zhao H et al (2017) The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun 8:845. https://doi.org/10.1038/s41467-017-00900-1
Jin T et al (2012) Structures of the HIN domain: DNA complexes reveal ligand binding and activation mechanisms of the AIM2 inflammasome and IFI16 receptor. Immunity 36(4):561–571
Jin C, Henao-Mejia J, Flavell RA (2013) Innate immune receptors: key regulators of metabolic disease progression. Cell Metab 17(6):873–882
Jones ML, Martoni CJ, Parent M, Prakash S (2012) Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic adults. Br J Nutr 107:1505–1513
Kamada N, Nunez G (2014) Regulation of the immune system by the resident intestinal bacteria. Gastroenterology 146:1477–1488
Karlsson FH, Fak F, Nookaew I, Tremaroli V, Fagerberg B, Petranovic D et al (2012) Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun 3:1245
Kasselman LJ, Vernice NA, DeLeon J, Reiss AB (2018) The gut microbiome and elevated cardiovascular risk in obesity and autoimmunity. Atherosclerosis 271:203–213
Khalili L, Alipour B, AsghariJafarabadi M, Hassanalilou T, Mesgari Abbasi M, Faraji I (2019) Probiotic assisted weight management as a main factor for glycemic control in patients with type 2 diabetes: a randomized controlled trial. Diabetol Metab Syndr 11(1):1–9
Kim S, Goel R, Kumar A, Qi Y, Lobaton G, Hosaka K et al (2018) Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure. Clin Sci 132:701–718
Kimura I, Ozawa K, Inoue D, Imamura T, Kimura K, Maeda T, Terasawa K, Kashihara D, Hirano K, Tani T, Takahashi T (2013) The gut microbiota suppresses insulin mediated fat accumulation via short-chain fatty acid receptor GPR43. Nat Commun J 4:1829
Kiouptsi K, Finger S, Garlapati VS, Knorr M, Brandt M, Walter U, Wenzel P, Reinhardt C (2019) Hypoxia evokes increased PDI and PDIA6 expression in the infarcted myocardium of ex-germ-free and conventionally raised mice. Biol Open 8:bio038851. https://doi.org/10.1242/bio.038851
Kociol RD, Pang PS, Gheorghiade M, Fonarow GC, O’Connor CM, Felker GM (2010) Troponin elevation in heart failure: prevalence, mechanisms, and clinical implications. J Am Coll Cardiol 56(14):1071–1078
Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT et al (2013) Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 19(5):576–585
Koeth RA, Levison BS, Culley MK, Buffa JA, Wang Z, Gregory JC et al (2014) gamma-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to tmao. Cell Metab 20(5):799–812
Koeth RA, Lam-Galvez BR, Kirsop J, Wang Z, Levison BS, Gu X, Copeland MF, Bartlett D, Cody DB, Dai HJ, Culley MK, Li XS, Fu X, Wu Y, Li L, DiDonato JA, Tang WHW, Garcia-Garcia JC, Hazen SL (2019) L-Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans. J Clin Invest 129:373–387
Krznaric Z, Vranesic Bender D, Mestrovic T (2019) The Mediterranean diet and its association with selected gut bacteria. Curr Opin Clin Nutr Metab Care 22:401–406
Lai ZL, Tseng CH, Ho HJ, Cheung CK, Lin JY, Chen YJ, Cheng FC, Hsu YC, Lin JT, El-Omar EM, Wu CY (2018) Fecal microbiota transplantation confers beneficial metabolic effects of diet and exercise on diet-induced obese mice. Sci Rep 8(1):1
Lam V, Su J, Koprowski S, Hsu A, Tweddell JS, Rafiee P, Gross GJ, Salzman NH, Baker JE (2012) Intestinal microbiota determine severity of myocardial infarction in rats. FASEB J 26:1727–1735. https://doi.org/10.1096/fj.11-197921
Larsson E, Tremaroli V, Lee YS, Koren O, Nookaew I, Fricker A et al (2012) Analysis of gut microbial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through MyD88. Gut 61:1124–1131
Le Roy T, Lécuyer E, Chassaing B, Rhimi M, Lhomme M, Boudebbouze S, Ichou F, Haro Barceló J, Huby T, Guerin M, Giral P (2019) The intestinal microbiota regulates host cholesterol homeostasis. BMC Biol 17(1):1–8
Ley RE, Turnbaugh PJ, Klein S, Gordon JI (2006) Human gut microbes associated with obesity. Nature 444(7122):1022–1023
Li XS, Obeid S, Klingenberg R, Gencer B, Mach F, Räber L, Windecker S, Rodondi N, Nanchen D, Muller O et al (2017) Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors. Eur Heart J 38:814–824. https://doi.org/10.1093/eurheartj/ehw582
Li XS, Wang Z, Cajka T, Buffa JA, Nemet I, Hurd AG et al (2018) Untargeted metabolomics identifies trimethyllysine, a TMAO-producing nutrient precursor, as a predictor of incident cardiovascular disease risk. JCI Insight 3(6):e99096
Li H, Liu B, Song J, An Z, Zeng X, Li J et al (2019a) Characteristics of gut microbiota in patients with hypertension and/or hyperlipidemia: a cross-sectional study on rural residents in Xinxiang County, Henan Province. Microorganisms 7:E399. https://doi.org/10.3390/microorganisms7100399
Li XS, Obeid S, Wang Z, Hazen BJ, Li L, Wu Y et al (2019b) Trimethyllysine, a trimethyl-amine N-oxide precursor, provides near- and long-term prognostic value in patients presenting with acute coronary syndromes. Eur Heart J 40(32):2700–2709
Li Q, Chang Y, Zhang K, Chen H, Tao S, Zhang Z (2020) Implication of the gut microbiome composition of type 2 diabetic patients from northern China. Sci Rep 10(1):1–8
Liu T, Hougen H, Vollmer AC, Hiebert SM (2012) Gut bacteria profiles of Mus musculus at the phylum and family levels are influenced by saturation of dietary fatty acids. Anaerobe 18:331–337
Loke WM, Proudfoot JM, Hodgson JM, McKinley AJ, Hime N, Magat M et al (2010) Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein e-knockout mice by alleviating inflammation and endothelial dysfunction. Arterioscler Thromb Vasc Biol 30:749–757
Macfarlane GT, Macfarlane S (2011) Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics. J Clin Gastroenterol 45(suppl):S120–S127
Mahida YR, Rolfe VE (2004) Host-bacterial interactions in inflammatory bowel disease. Clin Sci 107:331–341
Marchesi JR, Adams DH, Fava F et al (2016) The gut microbiota and host health: a new clinical frontier. Gut 65:330–339
Marques FZ et al (2018) Beyond gut feelings: how the gut microbiota regulates blood pressure. Nat Rev Cardiol 15:20–32. https://doi.org/10.1038/nrcardio.2017.120
May-Zhang LS, Chen Z, Dosoky NS, Yancey PG, Boyd KL, Hasty AH et al (2019) Administration of N-acyl-phosphatidylethanolamine expressing bacteria to low density lipoprotein receptor(-/-) mice improves indices of cardiometabolic disease. Sci Rep 9:420
Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL (2005) An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122(1):107–118
McCafferty K, Byrne C, Yaqoob M (2012) Intestinal microbiota determine severity of myocardial infarction in rats. FASEB J 26(11):4388. author reply 4388-9
McMillan A, Hazen S (2019) Gut microbiota involvement in ventricular remodeling post–myocardial infarction. Circulation 139(5):660–662
McNeil NI (1984) The contribution of the large intestine to energy supplies in man. Am J Clin Nutr 39:338–342
Meijers BK, De Preter V, Verbeke K, Vanrenterghem Y, Evenepoel P (2010) p-Cresylsulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin. Nephrol Dial Transplant 25(1):219–224
Mishima E, Fukuda S, Shima H, Hirayama A, Akiyama Y, Takeuchi Y, Fukuda NN, Suzuki T, Suzuki C, Yuri A, Kikuchi K (2015) Alteration of the intestinal environment by lubiprostone is associated with amelioration of adenine-induced CKD. J Am Soc Nephrol 26(8):1787–1794
Miura K, Greenland P, Stamler J, Liu K, Daviglus ML, Nakagawa H (2004) Relation of vegetable, fruit, and meat intake to 7-year blood pressure change in middle-aged men: the Chicago Western Electric Study. Am J Epidemiol 159:572–580
Moludi J, Kafil HS, Qaisar SA, Gholizadeh P, Alizadeh M, Vayghyan HJ (2021) Effect of probiotic supplementation along with calorie restriction on metabolic endotoxemia, and inflammation markers in coronary artery disease patients: a double blind placebo controlled randomized clinical trial. Nutr J 20(1):1
Morgan XC, Huttenhower C (2012) Chapter 12: human microbiome analysis. PLoS Comput Biol 8:e1002808
Nagatomo Y, Tang WW (2015) Intersections between microbiome and heart failure: revisiting the gut hypothesis. J Card Fail 21(12):973–980
Nallu A, Sharma S, Ramezani A, Muralidharan J, Raj D (2017) Gut microbiome in chronic kidney disease: challenges and opportunities. Transl Res 179:24–37
Naqvi S, Asar T, Kumar V, Al-Abbasi F, Alhayyani S, Kamal M, Anwar F (2021) A cross-talk between gut microbiome, salt and hypertension. Biomed Pharmacother 134:111156. https://doi.org/10.1016/j.biopha.2020.111156
Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, Poole-Wilson PA, Coats AJ, Anker SD (1999) Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 353(9167):1838–1842
Norman JM, Handley SA, Virgin HW (2014) Kingdom-agnostic metagenomics and the importance of complete characterization of enteric microbial communities. Gastroenterology 146:1459–1469
Novakovic M, Rout A, Kingsley T, Kirchoff R, Singh A, Verma V, Kant R, Chaudhary R (2020) Role of gut microbiota in cardiovascular diseases. World J Cardiol 12(4):110–122. https://doi.org/10.4330/wjc.v12.i4.110. PMID: 32431782; PMCID: PMC7215967.
Organ CL, Otsuka H, Bhushan S, Wang Z, Bradley J, Trivedi R, Polhemus DJ, Tang WW, Wu Y, Hazen SL, Lefer DJ (2016) Choline diet and its gut microbe–derived metabolite, trimethylamine N-oxide, exacerbate pressure overload–induced heart failure. Circulation 9(1):e002314
Pascal M, Perez-Gordo M, Caballero T et al (2018) Microbiome and allergic diseases. Front Immunol 9:1584
Pasini E, Aquilani R, Testa C, Baiardi P, Angioletti S, Boschi F, Verri M, Dioguardi F (2016) Pathogenic gut flora in patients with chronic heart failure. JACC Heart Fail 4(3):220–227
Pevsner-Fischer M, Blacher E, Tatirovsky E, Ben-Dov IZ, Elinav E (2017) The gut microbiome and hypertension. Curr Opin Nephrol Hypertens 26:1–8. https://doi.org/10.1097/MNH.0000000000000293
Phillips CM, Harrington JM, Perry IJ (2018) Relationship between dietary quality, determined by DASH score, and cardiometabolic health biomarkers: a cross-sectional analysis in adults. Clin Nutr 38(4):1620–1628. https://doi.org/10.1016/j.clnu.2018.08.028
Pisarenko OI, Khlopkov VN, Ruuge EK (1986) A 1H NMR study of succinate synthesis from exogenous precursors in oxygen-deprived rat heart mitochondria. Biochem Int 12:145–153
Pluznick JL (2013) Renal and cardiovascular sensory receptors and blood pressure regulation. Am J Physiol Renal Physiol 305:F439–F444
Rafter J (2004) The effects of probiotics on colon cancer development. Nutr Res Rev 17(2):277–284
Rajilic-Stojanovic M, de Vos WM (2014) The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev 38:996–1047
Ramezani A, Raj DS (2014) The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol 25(4):657–670
Reid T, Schloss PD (2014) Dynamics and associations of microbial community types across the human body. Nature 509(7500):357–360
Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C et al (2017) Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 377(12):1119–1131
Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano GA, Gasbarrini A, Mele MC (2019) What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms 7(1):14
Rook G, Backhed F, Levin BR, McFall-Ngai MJ, McLean AR (2017) Evolution, human-microbe interactions, and life history plasticity. Lancet 390:521–530
Ross R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340(2):115–126
Samuel BS, Shaito A, Motoike T, Rey FE, Backhed F, Manchester JK, Hammer RE, Williams SC, Crowley J, Yanagisawa M, Gordon JI (2008) Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci 105(43):16767–16772
Saneei P, Hashemipour M, Kelishadi R, Esmaillzadeh A (2014) The dietary approaches to stop hypertension (DASH) diet affects inflammation in childhood metabolic syndrome: a randomized cross-over clinical trial. Ann Nutr Metab 64:20–27
Santoru ML, Piras C, Murgia A, Palmas V, Camboni T, Liggi S et al (2017) Cross sectional evaluation of the gut-microbiome metabolome axis in an Italian cohort of IBD patients. Sci Rep 7:9523
Sayin SI, Wahlström A, Felin J, Jäntti S, Marschall HU, Bamberg K, Angelin B, Hyötyläinen T, Orešič M, Bäckhed F (2013) Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 17(2):225–235
Schoeler M, Caesar R (2019) Dietary lipids, gut microbiota and lipid metabolism. Rev Endocr Metab Disord 20(4):461–472
Schwiertz A, Taras D, Schafer K et al (2010) Microbiota and SCFA in lean and overweight healthy subjects. Obesity 18:190–195
Shikata F, Shimada K, Sato H, Ikedo T, Kuwabara A, Furukawa H et al (2019) Potential influences of gut microbiota on the formation of intracranial aneurysm. Hypertension 73:491–496
Silveira-Nunes G, Durso DF Jr, Luiz Roberto AO, Cunha EHM, Maioli TU, Vieira AT, Speziali E, Corr Aaa-Oliveira R, Martins-Filho OA, Teixeira-Carvalho A, Franceschi C, Rampelli S, Turroni S, Brigidi P, Faria AMC (2020) Hypertension is associated with intestinal microbiota dysbiosis and inflammation in a Brazilian population. Front Pharmacol. https://doi.org/10.3389/fphar.2020.00258
Simenhoff ML, Dunn SR, Zollner GP, Fitzpatrick ME, Emery SM, Sandine WE, Ayres JW (1996) Biomodulation of the toxic and nutritional effects of small bowel bacterial overgrowth in end-stage kidney disease using freeze-dried Lactobacillus acidophilus. Miner Electrolyte Metab 22(1-3):92–96
Simpson HL, Campbell BJ (2015) Review article: dietary fibre-microbiota interactions. Aliment Pharmacol Ther 42:158–179
Skagen K, Troseid M, Ueland T, Holm S, Abbas A, Gregersen I et al (2016) The carnitine-butyrobetaine-trimethylamine-n-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis. Atherosclerosis 247:64–69
Smith PM, Howitt MR, Panikov N et al (2013) The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341:569–573
Song L, Xu M, Lopes-Virella MF, Huang Y (2001) Quercetin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells through extracellular signal-regulated kinase. Arch Biochem Biophys 391:72–78
Straub RH, Pongratz G, Weidler C, Linde HJ, Kirschning CJ, Gluck T, Scholmerich J, Falk W (2005) Ablation of the sympathetic nervous system decreases gram-negative and increases gram-positive bacterial dissemination: key roles for tumor necrosis factor/phagocytes and interleukin-4/lymphocytes. J Infect Dis 192:560–572
Sun S, Lulla A, Sioda M, Winglee K, Wu MC, Jacobs DR Jr, Shikany JM, Lloyd-Jones DM, Launer LJ, Fodor AA, Meyer KA (2019) Gut microbiota composition and blood pressure. Hypertension 73:998–1006. https://doi.org/10.1161/HYPERTENSIONAHA.118.12109
Sureda A, Bibiloni MDM, Julibert A, Bouzas C, Argelich E, Llompart I, Pons A, Tur JA (2018) Adherence to the Mediterranean diet and inflammatory markers. Nutrients 10:62
Suzuki T, Heaney LM, Bhandari SS, Jones DJ, Ng LL (2016) Trimethylamine N-oxide and prognosis in acute heart failure. Heart 102(11):841–848
Suzuki T, Heaney LM, Jones DJ, Ng LL (2017) Trimethylamine N-oxide and risk stratification after acute myocardial infarction. Clin Chem 63:420–428
Tang WH, Hazen SL (2014) The contributory role of gut microbiota in cardiovascular disease. J Clin Invest 124:4204–4211
Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X et al (2013) Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med 368(17):1575–1584
Tang WW, Wang Z, Fan Y, Levison B, Hazen JE, Donahue LM, Wu Y, Hazen SL (2014) Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis. J Am Coll Cardiol 64(18):1908–1914
Tang TVH, Chen H-C, Chen C-Y, Yen CYT, Lin C-J, Prajnamitra RP, Chen L-L, Ruan S-C, Lin J-H, Lin P-J, Lu H-H, Kuo CW, Chang CM, Hall AD, Vivas EI, Shui J-W, Chen P, Hacker TA, Rey FE, Kamp TJ, Hsieh PCH (2019) Loss of gut microbiota alters immune system composition and cripples postinfarction cardiac repair. Circulation 139:647–659. https://doi.org/10.1161/CIRCULATIONAHA.118.03523
Tilg H (2016) A gut feeling about thrombosis. N Engl J Med 374(25):2494–2496
Ursell LK, Haiser HJ, Van Treuren W et al (2014) The intestinal metabolome: an intersection between microbiota and host. Gastroenterology 146:1470–1476
Vinje S, Stroes E, Nieuwdorp M, Hazen SL (2014) The gut microbiome as novel cardio-metabolic target: the time has come! Eur Heart J 35:883–887
Waite JC, Skokos D (2012) Th17 response and inflammatory autoimmune diseases. Int J Inflamm 2012:819467
Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B et al (2011) Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472(7341):57–63
Wang Z, Roberts AB, Buffa JA, Levison BS, Zhu W, Org E, Gu X, Huang Y, Zamanian-Daryoush M, Culley MK, DiDonato AJ (2015) Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell 163(7):1585–1595
Wang Z, Bergeron N, Levison BS, Li XS, Chiu S, Jia X et al (2019) Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women. Eur Heart J 40(7):583–594
Wang H, Lu Y, Yan Y, Tian S, Zheng D, Leng D, Wang C, Jiao J, Wang Z, Bai Y (2020) Promising treatment for type 2 diabetes: fecal microbiota transplantation reverses insulin resistance and impaired islets. Front Cell Infect Microbiol 9:455
Weaver CT, Hatton RD, Mangan PR et al (2007) IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 25:821–852
Whiteside SA, Razvi H, Dave S, Reid G, Burton JP (2015) E microbiome of the urinary tract—a role beyond infection. Nat Rev Urol 12(2):81–90
Widmer RJ, Flammer AJ, Lerman LO, Lerman A (2015) The Mediterranean diet, its components, and cardiovascular disease. Am J Med 128:229–238
Wlodarska M et al (2014) NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion. Cell 156(5):1045–1059
Wu GD, Chen J, Hoffmann C et al (2011) Linking long-term dietary patterns with gut microbial enterotypes. Science 334:105–108
Wu ZX, Li SF, Chen H, Song JX, Gao YF, Zhang F et al (2017a) The changes of gut microbiota after acute myocardial infarction in rats. PLoS One 12:e0180717
Wu Y, Zhang Q, Ren Y, Ruan Z (2017b) Effect of probiotic Lactobacillus on lipid profile: a systematic review and meta-analysis of randomized, controlled trials. PLoS One 12(6):e0178868
Wu D, Guan L, Jiang YX, Ma SH, Sun YN, Lei HT et al (2019a) Microbiome and metabonomics study of quercetin for the treatment of atherosclerosis. Cardiovasc Diagn Ther 9:545–560
Wu W, Chen C, Liu P, Panyod S, Liao B, Chen P, Kao H, Kuo H, Kuo C, Chiu THT, Chen R, Chuang H, Huang Y, Zou H, Hsu C, Chang T, Lin C, Ho C, Yu H, Sheen L, Wu M (2019b) Identification of TMAO-producer phenotype and host–diet–gut dysbiosis by carnitine challenge test in human and germ-free mice. Gut 68:1439–1449
Xiao L, Liu L, Guo X, Zhang S, Wang J, Zhou F et al (2017) Quercetin attenuates high fat diet-induced atherosclerosis in apolipoprotein E knockout mice: a critical role of nadph oxidase. Food Chem Toxicol 105:22–33
Xu H, Wang X, Feng W, Liu Q, Zhou S, Liu Q, Cai L (2020) The gut microbiota and its interactions with cardiovascular disease. Microb Biotechnol 13(3):637–656. https://doi.org/10.1111/1751-7915.13524
Yadav R, Khan SH, Mada SB, Meena S, Kapila R, Kapila S (2019) Consumption of probiotic Lactobacillus fermentum MTCC: 5898-fermented milk attenuates dyslipidemia, oxidative stress, and inflammation in male rats fed on cholesterol-enriched diet. Probiot Antimicrob Prot 11(2):509–518
Yilmaz P, Parfrey LW, Yarza P et al (2014) e SILVA and “all species living tree project (LTP)” taxonomic frameworks. Nucleic Acids Res 42:D643–D648
Yu HN, Zhu J, Pan WS, Shen SR, Shan WG, Das UN (2014) Effects of fish oil with a high content of n-3 polyunsaturated fatty acids on mouse gut microbiota. Arch Med Res 45:195–202
Zabell A, Tang WH (2017) Targeting the microbiome in heart failure. Curr Treat Options Cardiovasc Med 19(4):27
Zeng Z, Yuan Q, Yu R, Zhang J, Ma H, Chen S (2019) Ameliorative effects of probiotic Lactobacillus paracasei NL41 on insulin sensitivity, oxidative stress, and beta-cell function in a type 2 diabetes mellitus rat model. Mol Nutr Food Res 63(22):1900457
Zheng Y, Yu B, Alexander D, Mosley T, Heiss G, Nettleton J, Boerwinkle E (2013) Metabolomics and incident hypertension among blacks. Hypertension 62(2):398–403. https://doi.org/10.1161/hypertensionaha.113.01166
Zhu W et al (2016) Gut microbial metabolite TMAO enhances platelet Hyperreactivity and thrombosis risk. Cell 165(1):111–124
Zhu W et al (2017) Gut microbe-generated trimethylamine N-oxide from dietary choline is prothrombotic in subjects. Circulation 135(17):1671–1673
Zhu Q, Gao R, Zhang Y, Pan D, Zhu Y, Zhang X et al (2018) Dysbiosis signatures of gut microbiota in coronary artery disease. Physiol Genomics 50(10):893–903
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kumar, S. et al. (2023). Influence of the Gut Microbiome on Cardiovascular Health and Hypertension. In: Sobti, R., Kuhad, R.C., Lal, R., Rishi, P. (eds) Role of Microbes in Sustainable Development. Springer, Singapore. https://doi.org/10.1007/978-981-99-3126-2_15
Download citation
DOI: https://doi.org/10.1007/978-981-99-3126-2_15
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-3125-5
Online ISBN: 978-981-99-3126-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)